eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | central retinal vein occlusion |
| Comorbidity | C0271051|macular edema |
| Sentences | 49 |
| PubMedID- 23842103 | Purpose: to evaluate the association between vitreous fluid levels of inflammatory factors and macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 25576994 | Therapies for macular edema associated with central retinal vein occlusion: a report by the american academy of ophthalmology. |
| PubMedID- 21275514 | Purpose: to investigate whether pigment epithelium-derived factor (pedf) or vascular endothelial growth factor (vegf) influences macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 22105941 | Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion. |
| PubMedID- 20453544 | The outcome of vitrectomy for macular edema was examined in patients with central retinal vein occlusion (crvo), as well as whether vascular endothelial growth factor (vegf) and interleukin-6 (il-6) levels in vitreous fluid influence the visual prognosis and macular edema. |
| PubMedID- 25634982 | Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema. |
| PubMedID- 21978179 | Intravitreal bevacizumab for macular edema due to central retinal vein occlusion: perfused vs. |
| PubMedID- 24205253 | Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review. |
| PubMedID- 21764136 | Objective: to evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal implant (dex implant) over 12 months in eyes with macular edema owing to branch or central retinal vein occlusion (brvo or crvo). |
| PubMedID- 22824618 | A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision. |
| PubMedID- 23709332 | Macular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion. |
| PubMedID- 19967679 | Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion. |
| PubMedID- 20432959 | Purpose: to examine the short-term effects of intravitreal injections of bevacizumab on macular edema due to central retinal vein occlusion (crvo). |
| PubMedID- 23690676 | Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: a case report. |
| PubMedID- 22044337 | Rapid resolution of macular edema associated with central retinal vein occlusion using ranibizumab after failure with multiple bevacizumab injections. |
| PubMedID- 21087958 | Predictors of short-term visual outcome after anti-vegf therapy of macular edema due to central retinal vein occlusion. |
| PubMedID- 24828198 | Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections. |
| PubMedID- 23379834 | Changes of macular sensitivity and morphology after pars plana vitrectomy for macular edema with central retinal vein occlusion: a case series. |
| PubMedID- 24688266 | The score (standard care vs corticosteroid for retinal vein occlusion) study revealed the benefit of steroid treatment in central retinal vein occlusion (crvo) associated with macular edema (me) [1]. |
| PubMedID- 20658459 | The patients were divided into the 3 following groups: group 1 (nonproliferative diabetic retinopathy), group 2 (choroidal neovascularization secondary to age-related macular degeneration), and group 3 (macular edema with branch or central retinal vein occlusion). |
| PubMedID- 22823029 | Bevacizumab, a monoclonal antibody against vascular endothelial growth factor (vegf), is widely used for the treatment of macular edema associated with central retinal vein occlusion (crvo). |
| PubMedID- 24847256 | We report a 19-year-old patient who developed a central retinal vein occlusion (crvo) with significant macular edema and visual impairment following intense exercise and dehydration. |
| PubMedID- 25902119 | Patients and methods: we describe a retrospective series of patients followed in the medical retina unit of the jules gonin eye hospital for macular edema due to ischemic central retinal vein occlusion, refractory to monthly retreatment with ranibizumab, and changed to aflibercept. |
| PubMedID- 20935688 | Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment. |
| PubMedID- 23433821 | We report the case of anterior chamber migration of a dexamethasone implant (ozurdex((r))) in a 54-year-old woman with macular edema due to a central retinal vein occlusion. |
| PubMedID- 25383828 | Results: initial ophthalmic examination showed bilateral central retinal vein occlusion with macular edema, including serous macular detachment in the left eye. |
| PubMedID- 22668313 | Purpose: to investigate the visual and anatomical effects of intravitreal bevacizumab treatment of macular edema due to central retinal vein occlusion (crvo). |
| PubMedID- 25902116 | Recurrent macular edema in central retinal vein occlusion treated with intravitreal ranibizumab using a modified treat and extend regimen. |
| PubMedID- 21598607 | [medium-term effects of intravitreal bevacizumab for macular edema associated with central retinal vein occlusion]. |
| PubMedID- 22902212 | Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. |
| PubMedID- 24531560 | central retinal vein occlusion (crvo) often leads to macular edema, which is the most frequent cause of visual impairment in crvo patients. |
| PubMedID- 20827142 | Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. |
| PubMedID- 22991926 | Retinal function and morphology in central retinal vein occlusion with macular edema. |
| PubMedID- 23673531 | Objective: to review the pharmacology, efficacy, and safety data available for aflibercept and compare the drug to other therapeutic options for treatment of macular edema following central retinal vein occlusion (crvo) to determine its likely role in therapy. |
| PubMedID- 23046435 | Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion. |
| PubMedID- 24940042 | Aims: to determine if intravitreal bevacizumab combined with the dexamethasone intravitreal implant 0.7 mg improves visual acuity and macular thickness more than bevacizumab monotherapy in eyes with macular edema due to branch and central retinal vein occlusions. |
| PubMedID- 21538003 | Vitreous inflammatory factors in macular edema with central retinal vein occlusion. |
| PubMedID- 22925843 | Patients and methods: the present study represents a retrospective review of eight patients presenting with central retinal vein occlusion complicated by macular edema with central foveolar thickness greater than 350 mum by cirrus-oct, zeiss. |
| PubMedID- 26247458 | He developed a central retinal vein occlusion complicated by macular edema and received treatment with intravitreal bevacizumab, which led to resolution of the edema. |
| PubMedID- 23764703 | This new technique is a promising treatment of macular edema due to central retinal vein occlusion. |
| PubMedID- 21350277 | A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision. |
| PubMedID- 22562161 | macular edema in central retinal vein occlusion: correlation between optical coherence tomography, angiography and visual acuity. |
| PubMedID- 23713337 | [ozurdex, modern therapy for macular edema in central retinal vein occlusion]. |
| PubMedID- 23869159 | We describe the development of central retinal venous occlusion with associated cystoid macular edema (cme) in two healthy infertile women who were recruited for in vitro fertilization cycle for infertility. |
| PubMedID- 22424833 | Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. |
| PubMedID- 22615698 | Resolution of persistent cystoid macular edema due to central retinal vein occlusion in a vitrectomized eye following intravitreal implant of dexamethasone 0.7 mg. |
| PubMedID- 23629792 | Patients and methods: eyes with a macular edema due to a central retinal vein occlusion or to a branch retinal vein occlusion were considered if at least 3 intravitreal injections of bevacizumab (1.25 mg) or ranibizumab (0.5 mg) had been performed. |
| PubMedID- 19763601 | Background: to evaluate prognostic factors of response to intravitreal bevacizumab therapy of macular edema (me) due to central retinal vein occlusion (crvo) or branch retinal vein occlusion (brvo). |
| PubMedID- 26117932 | The paper presents the first results concerning the aflibercept (eylea) treatment, the last antivegf approved for treatment of the age related macular degeneration (amd), neovascular form and for macular edema due to the central retinal vein occlusion. |
Page: 1